A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia

Double Blind ◽

Residual Symptoms ◽

Double Blind Placebo ◽

Receptor Antibody ◽

Double-Blind Randomized Controlled Clinical Trial of the Interleukin-6 Receptor Antagonist, Tocilizumab, in European Patients With Rheumatoid Arthritis Who Had an Incomplete Response to Methotrexate

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70006-3 ◽

2007 ◽

Vol 2007 ◽

pp. 8-10

Author(s):

D.L. Kimpel

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Receptor Antagonist ◽

Interleukin 6 ◽

Randomized Controlled Clinical Trial ◽

Double Blind ◽

Randomized Controlled ◽

Incomplete Response ◽

Anti–interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study

Arthritis & Rheumatism ◽

10.1002/art.21826 ◽

2006 ◽

Vol 54 (6) ◽

pp. 1778-1785 ◽

Cited By ~ 28

Author(s):

Rainer H. Straub ◽

Peter Härle ◽

Seizo Yamana ◽

Takemasa Matsuda ◽

Kiyoshi Takasugi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Interleukin 6 ◽

Antibody Therapy ◽

Controlled Study ◽

Adrenal Androgen ◽

Double Blind ◽

Double Blind Placebo ◽

Receptor Antibody ◽

Interleukin 6 Receptor ◽

Androgen Secretion

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

Arthritis & Rheumatism ◽

10.1002/art.22033 ◽

2006 ◽

Vol 54 (9) ◽

pp. 2817-2829 ◽

Cited By ~ 520

Author(s):

R. N. Maini ◽

P. C. Taylor ◽

J. Szechinski ◽

K. Pavelka ◽

J. Bröll ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Receptor Antagonist ◽

Interleukin 6 ◽

Randomized Controlled Clinical Trial ◽

Double Blind ◽

Randomized Controlled ◽

Incomplete Response ◽

Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: Results of a randomized double-blind, placebo-controlled clinical trial

International Immunopharmacology ◽

10.1016/j.intimp.2013.09.020 ◽

2013 ◽

Vol 17 (3) ◽

pp. 917-923 ◽

Cited By ~ 36

Author(s):

Mohammad Taraz ◽

Mohammad-Reza Khatami ◽

Simin Dashti-Khavidaki ◽

Shahin Akhonzadeh ◽

Ahmad-Ali Noorbala ◽

...

Keyword(s):

Clinical Trial ◽

Serum Level ◽

Interleukin 6 ◽

Hemodialysis Patients ◽

Double Blind ◽

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial

Arthritis & Rheumatism ◽

10.1002/art.20303 ◽

2004 ◽

Vol 50 (6) ◽

pp. 1761-1769 ◽

Cited By ~ 563

Author(s):

Norihiro Nishimoto ◽

Kazuyuki Yoshizaki ◽

Nobuyuki Miyasaka ◽

Kazuhiko Yamamoto ◽

Shinichi Kawai ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Interleukin 6 ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Receptor Antibody ◽

Test 1: Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial

Gene ◽

10.1016/s0378-1119(15)30104-4 ◽

2015 ◽

Author(s):

Jerry Lewis ◽

Lauren Bacall ◽

Humphrey Bogart ◽

Gene Kelly

Keyword(s):

Clinical Trial ◽

Double Blind ◽

Double blind placebo controlled clinical trial of homoeopathic medicines in HIV infection

British Homeopathic Journal ◽

10.1038/sj.bhj.5800206 ◽

1998 ◽

Vol 87 (2) ◽

pp. 86-88

Author(s):

D P Rastogi ◽

V P Singh ◽

Vikram Singh ◽

S K Dey ◽

K Rao

Keyword(s):

Clinical Trial ◽

Hiv Infection ◽

Double Blind ◽

Faculty Opinions recommendation of Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108512.564581 ◽

2008 ◽

Author(s):

Johanne Martel-Pelletier ◽

Jean-Pierre Raynauld

Keyword(s):

Rheumatoid Arthritis ◽

Interleukin 6 ◽

Randomised Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Receptor Inhibition ◽

A Magnetic Resonance Spectroscopy Study of Lovastatin for Treating Bipolar Mood Disorder: A 4-Week Randomized Double-Blind, Placebo- Controlled Clinical Trial

Recent Patents on Inflammation & Allergy Drug Discovery ◽

10.2174/1872213x10666161028153258 ◽

2017 ◽

Vol 10 (2) ◽

pp. 133-141 ◽

Cited By ~ 2

Author(s):

Mehrzad Lotfi ◽

Sara Shafiee ◽

Ahmd Ghanizadeh ◽

Motahar O. Sigaroudi ◽

Leila Razeghian

Keyword(s):

Clinical Trial ◽

Magnetic Resonance ◽

Magnetic Resonance Spectroscopy ◽

Resonance Spectroscopy ◽

Spectroscopy Study ◽

Double Blind ◽

Double Blind Placebo ◽

Magnetic Resonance Spectroscopy Study ◽

Bipolar Mood Disorder

Beneficial effect of Burdock complex on asymptomatic Helicobacter pylori- infected subjects: A randomized, double-blind placebo-controlled clinical trial

Helicobacter ◽

10.1111/hel.12469 ◽

2018 ◽

Vol 23 (3) ◽

pp. e12469 ◽

Cited By ~ 3

Author(s):

Chi-Hua Yen ◽

Hui-Fang Chiu ◽

Su-Yu Huang ◽

Yan-Ying Lu ◽

Yi-Chun Han ◽

...

Keyword(s):

Clinical Trial ◽

Helicobacter Pylori ◽

Beneficial Effect ◽

Double Blind ◽